Induction of neuroblastoma maturation by a new chemotherapy protocol
- 1 January 1982
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 10 (3) , 275-282
- https://doi.org/10.1002/mpo.2950100308
Abstract
Five patients, 1.5 to 9 years old, were treated at M.D. Anderson Hospital for Stage III or IV neuroblastoma. Each was entered into a chemotherapy protocol which included cyclophosphamide, vincristine, 5‐trifluoromethyl‐2′‐deoxyuridine (F3TdR), and papaverine, and each responded with marked reduction in size of the abdominal tumor mass. All patients then underwent exploratory laparotomy and resection or biopsy of residual tumor. In three cases, histological examination of the treated tumor showed ganglioneuroblastoma with predominance of mature cells; one patient had a mature ganglioneuroma, whereas only necrotic tissue was obtained from the fifth patient. These findings support the hypothesis that this chemotherapy protocol can induce neuroblastoma maturation.Keywords
This publication has 4 references indexed in Scilit:
- A Rationale for the Treatment of Metastatic Neuroblastoma12JNCI Journal of the National Cancer Institute, 1976
- Neuroblastoma: Review of the literature and an examination of factors contributing to its enigmatic characterCancer Treatment Reviews, 1976
- Demonstration of cell-bound and humoral immunity against neuroblastoma cells.Proceedings of the National Academy of Sciences, 1968
- NeuroblastomaAnnals of Surgery, 1968